Cytosorbents Corp (CTSO) bonds
CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 2/30
$4.85−0.02 (-0.41%)
Close on Nov 16, 2026Market cap $304.79MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$17.24M
$14.15M due within a year
Net debt
$12.83M
After $4.41M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
–
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2023
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in Cytosorbents's 10-Q for the period ended Jun 30, 2026
| Issue | Coupon | Amount issued | Carrying value |
|---|---|---|---|
| Loan and Security Agreement Convertible at $1 a share | Floating + 5.00% | – | $17.50M |
| Tranche 1-Loan and Security Agreement | – | $10.00M | – |
| Tranche 2a-Loan and Security Agreement | – | $2.50M | – |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| First Tranche | $5.00M |
| Second Tranche | $5.00M |
| Third Tranche | $5.00M |
See a number that looks wrong?